ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 36

IFN-α Induces Altered Transitional B Cell Signaling and Function In Systemic Lupus Erythematosus

Joan E. Wither1, Nan-Hua Chang2, Timothy Li3, Julie Kim4, Carolina Landolt-Marticorena5, Paul R. Fortin6, Dafna D. Gladman7 and Murray B. Urowitz8, 11E420/Div of Rheumatology, Toronto Western Research Institute, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada, 2Genetics and Development, Toronto Western Research Institute, Toronto Western Hospital, Toronto, ON, Canada, 3Genetics and developmental biology, Toronto Western Hospital, Toronto, ON, Canada, 4Toronto Western Hospital, Toronto, ON, Canada, 5Rheumatology, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada, 6Medicine, Centre de Recherche du Chu de Québec et Université Laval, Quebec City, QC, Canada, 7University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 8Division of Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada

Meeting: ACR/ARHP Annual Meeting 2013

Keywords: B cells, Interferons and systemic lupus erythematosus (SLE)

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Title: B cell Function and Targeting in Systemic Lupus Erythematosus

Session Type: Abstract Submissions (ACR)

Background/Purpose: Previous experiments suggest that the B cells of lupus patients are hyper-responsive to B cell receptor engagement resulting in increased tyrosine phosphorylation and Ca2+mobilization.  However the precise B cell populations that are affected and the mechanisms leading to this hyper-responsiveness have yet to be determined.  In this study we have used Phosflow to address these questions.

Methods: PBMC were isolated from 27 healthy controls and 39 SLE patients with ≥ 4 ACR criteria.  Phosflow was used to assess the levels of p-SYK, p-PLCγ2, or p-ERK following Ig receptor engagement with goat anti-human IgM F(ab’)2in distinct B cell subsets defined by anti-CD19,-CD27, -IgD, -IgM and -CD38.  B cell proliferation and apoptosis following anti-IgM stimulation were assessed by flow cytometry, using CFSE and annexin V staining, respectively.  For some experiments, healthy control B cells were incubated with IFN-α, or 50% plasma ± anti-IFN or irrelevant Ab.  Lupus associated SNPs were determined by TaqMan genotyping.

Results: There were increased basal levels of p-SYK and p-ERK in naïve B cells (CD19+CD27–IgD+) from lupus patients as compared to controls.  The levels of basal p-SYK correlated with CD86 expression suggesting that these cells had already been activated in-vivo.  Following crosslinking with anti-IgM, there was a significant increase in the proportion of p-SYK+ cells above basal levels in the naïve B cell population of lupus patients as compared to controls. Similar trends were seen for the proportion of p-PLCγ2+ and p-ERK+ cells.  The increases seen in p-SYK+ cells were most marked for the transitional B cell subset (CD19+CD27–IgD+CD38hiIgMhi), where the levels of p-SYK correlated with enhanced proliferation and survival.   There was no correlation between lupus associated SNPs in BLK, LYN, PTPN22, and CSK, and the proportion of p-SYK+ cells following IgM crosslinking.  The proportion of p-SYK+cells in the transitional B cell subset fluctuated between visits, suggesting a possible role for pro-inflammatory factors.  Consistent with this, incubation of lupus plasma with control B cells enhanced SYK phosphorylation following IgM crosslinking, which was blocked by pre-incubation of plasma with anti-IFN but not irrelevant Ab.  Incubation of healthy control cells with recombinant IFN-α enhanced SYK phosphorylation, proliferation, and survival following IgM crosslinking, particularly of the transitional B cell subset.

Conclusion: IFN-α alters transitional B cell function leading to enhanced survival and proliferation.  As purging of transitional B cells plays an important role in preventing autoreactive B cells from entering the mature B cell pool, it is likely that elevated levels of IFN-α exacerbate the breach of B cell tolerance in lupus.


Disclosure:

J. E. Wither,
None;

N. H. Chang,
None;

T. Li,
None;

J. Kim,
None;

C. Landolt-Marticorena,
None;

P. R. Fortin,
None;

D. D. Gladman,

Janssen, Abbvie, Amgen, Pfizer, UCB, Novartis, Lily, Celgene,

2,

Janssen, Abbvie, Amgen, Pfizer, UCB, Novartis, Lily, Celgene,

5;

M. B. Urowitz,
None.

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR/ARHP Annual Meeting 2013

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ifn-%ce%b1-induces-altered-transitional-b-cell-signaling-and-function-in-systemic-lupus-erythematosus/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology